Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China · Delayed Price · Currency is CNY 20.91
-0.60 (-2.79%)
Aug 21, 2026, 3:00 PM CST
SHA:600332 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32,239 | 39,689 | 43,716 | 44,550 | 46,355 | 52,103 | |
Market Cap Growth | -23.67% | -9.21% | -1.87% | -3.90% | -11.03% | 16.71% |
Enterprise Value | 40,687 | 39,533 | 42,083 | 38,614 | 38,377 | 40,977 |
Last Close Price | 20.91 | 25.21 | 27.00 | 26.13 | 26.62 | 29.89 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.54 | 13.31 | 15.42 | 10.99 | 11.69 | 14.01 |
Forward PE | 10.83 | 12.97 | 13.11 | 10.47 | 12.61 | 14.55 |
PS Ratio | 0.41 | 0.51 | 0.58 | 0.59 | 0.66 | 0.76 |
PB Ratio | 0.78 | 0.99 | 1.16 | 1.22 | 1.38 | 1.66 |
P/TBV Ratio | 0.92 | 1.18 | 1.36 | 1.43 | 1.62 | 2.03 |
P/FCF Ratio | 19.76 | - | 18.89 | 18.00 | 8.26 | 11.79 |
P/OCF Ratio | 11.14 | - | 12.70 | 10.86 | 6.62 | 9.18 |
PEG Ratio | 2.27 | 2.29 | 4.99 | 1.20 | 0.73 | 0.86 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.52 | 0.51 | 0.56 | 0.51 | 0.54 | 0.59 |
EV/EBITDA Ratio | 9.96 | 10.29 | 9.72 | 7.07 | 7.67 | 9.33 |
EV/EBIT Ratio | 12.64 | 12.34 | 11.39 | 8.05 | 8.55 | 10.32 |
EV/FCF Ratio | 24.94 | - | 18.18 | 15.60 | 6.84 | 9.27 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.47 | 0.39 | 0.37 | 0.33 | 0.36 | 0.32 |
Debt / EBITDA Ratio | 5.34 | 3.84 | 3.04 | 2.09 | 2.30 | 2.14 |
Debt / FCF Ratio | 11.98 | - | 6.01 | 4.83 | 2.14 | 2.25 |
Net Debt / Equity Ratio | 0.15 | -0.20 | -0.23 | -0.28 | -0.38 | -0.40 |
Net Debt / EBITDA Ratio | 1.78 | -2.13 | -2.04 | -1.85 | -2.53 | -2.84 |
Net Debt / FCF Ratio | 3.83 | 5.56 | -3.81 | -4.08 | -2.25 | -2.82 |
Asset Turnover | 0.92 | 0.94 | 0.94 | 0.99 | 1.01 | 1.10 |
Inventory Turnover | 5.62 | 5.02 | 5.14 | 5.53 | 5.45 | 5.53 |
Quick Ratio | 0.97 | 1.17 | 1.11 | 1.17 | 1.20 | 1.27 |
Current Ratio | 1.65 | 1.57 | 1.48 | 1.55 | 1.53 | 1.64 |
Return on Equity (ROE) | 6.50% | 7.86% | 8.06% | 12.12% | 13.09% | 13.33% |
Return on Assets (ROA) | 2.08% | 2.41% | 2.88% | 3.91% | 3.98% | 3.94% |
Return on Invested Capital (ROIC) | 4.89% | 8.73% | 11.07% | 16.80% | 18.98% | 17.98% |
Return on Capital Employed (ROCE) | 5.80% | 7.10% | 8.60% | 11.30% | 12.00% | 11.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.95% | 7.52% | 6.49% | 9.10% | 8.56% | 7.14% |
FCF Yield | 5.06% | -3.71% | 5.29% | 5.56% | 12.11% | 8.48% |
Dividend Yield | 4.28% | 3.37% | 2.96% | 2.87% | 2.75% | 2.30% |
Payout Ratio | 67.61% | 55.23% | 79.38% | 39.09% | 37.58% | 34.03% |
Buyback Yield / Dilution | 0.01% | 0.01% | -0.02% | 0.02% | - | - |
Total Shareholder Return | 4.29% | 3.38% | 2.94% | 2.88% | 2.75% | 2.30% |